Showing results (1041-1050 of 1,710) with videos related to
Sort By:
Pageof 171
Endocrine-Related Cancer|March 24, 2000
Lessons from the use of aromatase inhibitors in the neoadjuvant settingJ M Dixon, C D Love, L Renshaw, et al.Breast Cancer Research : BCR|April 11, 2013
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?Alison F Munro, Annette Bartels, Eva Balslev, et al.Patient Education and Counseling|July 30, 2013
Patient knowledge and recall of health information following exposure to "facts and myths" message format variationsKenzie A Cameron, Michael E Roloff, Elisha M Friesema, et al.Journal of Racial and Ethnic Health Disparities|June 14, 2016
Understanding Black Patients' Refusal of Pneumococcal VaccinationTiffany Brown, Shira N Goldman, Francisco Acosta, et al.Molecular Cell|June 22, 2021
A cooperative PNPase-Hfq-RNA carrier complex facilitates bacterial riboregulationTom Dendooven, Dhriti Sinha, Alzbeta Roeselová, et al.Injury|April 15, 2018
Financial and recovery worry one year after traumatic injury: A prognostic, registry-based cohort studyL Ioannou, P A Cameron, S J Gibson, et al.Injury|November 29, 2024
Does injury type influence patient preference, response rates, and data completeness for online or telephone follow-up following injury?Lincoln M Tracy, Heather J Cleland, Richard N de Steiger, et al.British Journal of Cancer|May 31, 2001
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish studyD A Cameron, M C Cornbleet, R M Mackie, et al.Orbit (Amsterdam, Netherlands)|February 22, 2022
Radiological analysis of orbital lymphoma histological subtypesValerie Juniat, Cassie A Cameron, Kelsey Roelofs, et al.Annals of Surgery|April 29, 2008
Functional measures at discharge: are they useful predictors of longer term outcomes for trauma registries?Belinda J Gabbe, Pam M Simpson, Ann M Sutherland, et al.Pageof 171